These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


669 related items for PubMed ID: 10804043

  • 1. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain.
    Clemett D, Goa KL.
    Drugs; 2000 Apr; 59(4):957-80. PubMed ID: 10804043
    [Abstract] [Full Text] [Related]

  • 2. Rofecoxib: a review of its use in the management of osteoarthritis, acute pain and rheumatoid arthritis.
    Matheson AJ, Figgitt DP.
    Drugs; 2001 Apr; 61(6):833-65. PubMed ID: 11398914
    [Abstract] [Full Text] [Related]

  • 3. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
    Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS.
    JAMA; 1999 Nov 24; 282(20):1921-8. PubMed ID: 10580457
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
    Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC, Verburg KM, Geis GS.
    Mayo Clin Proc; 1999 Nov 24; 74(11):1095-105. PubMed ID: 10560596
    [Abstract] [Full Text] [Related]

  • 6. Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain.
    Fenton C, Keating GM, Wagstaff AJ.
    Drugs; 2004 Nov 24; 64(11):1231-61. PubMed ID: 15161329
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC.
    Semin Arthritis Rheum; 2002 Dec 24; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [Abstract] [Full Text] [Related]

  • 10. Celecoxib clinical profile.
    Tive L.
    Rheumatology (Oxford); 2000 Dec 24; 39 Suppl 2():21-8; discussion 57-9. PubMed ID: 11276798
    [Abstract] [Full Text] [Related]

  • 11. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS.
    Scand J Rheumatol Suppl; 1999 Dec 24; 109():31-7. PubMed ID: 10422544
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Upper gastroduodenal ulceration in arthritis patients treated with celecoxib.
    Ashcroft DM, Chapman SR, Clark WK, Millson DS.
    Ann Pharmacother; 2001 Dec 24; 35(7-8):829-34. PubMed ID: 11485128
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG, Zhao SZ, Burke TA, Zabinski RA, Makuch RW, Maurath CJ, Agrawal NM, Geis GS.
    J Rheumatol; 2000 Aug 24; 27(8):1876-83. PubMed ID: 10955327
    [Abstract] [Full Text] [Related]

  • 19. Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.
    Deeks JJ, Smith LA, Bradley MD.
    BMJ; 2002 Sep 21; 325(7365):619. PubMed ID: 12242171
    [Abstract] [Full Text] [Related]

  • 20. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
    Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL.
    Lancet; 2010 Jul 17; 376(9736):173-9. PubMed ID: 20638563
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.